Straumann Holdings AG acquired MegaGen Implant Co., Ltd. ("MegaGen")'s CB and will acquire 51% of equity interests in MegaGen through conversion of the CB in 2016, if certain conditions are satisfied. If 51% of the equity interest cannot be acquired, additional call options of up to 51% in equity interests from major shareholders can be exercised.